Custom application from SAS streamlines analysis, linking dynamic graphics, statistical details CARY, NC (Mar. 01, 2011) - JMP® Clinical 3, just released by business analytics leader SAS, offers new ...
Investing.com - JMP Securities maintained its Market Outperform rating and $18.00 price target on Larimar Therapeutics (NASDAQ:LRMR) stock on Tuesday. According to InvestingPro data, analysts are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback